Challenging the Stigma of Medical Weight Management
Gianna Beasley, a dietitian based in Denver, spent years navigating severe health challenges including insulin resistance and lupus. Despite her professional background, she struggled with chronic inflammation, joint pain, and brain fog that rendered daily tasks difficult. Doctors often advised her to simply adjust her diet and exercise routine. This conventional advice ignored the underlying biological reality of her condition. It took a move to a concierge medical practice for Beasley to access a GLP-1 medication. She has used the treatment for several years to manage symptoms that extend far beyond weight.
Beasley represents a growing cohort of healthcare professionals who are candid about their use of GLP-1 medications. Current data indicates that approximately 12 percent of adults in the United States use these drugs for conditions ranging from diabetes to weight management. Still, the societal stigma remains significant. Dietitians who take these medications often face public criticism from people who believe their choice contradicts their professional expertise. These critics argue that weight loss should occur through sheer willpower or traditional dietary changes, ignoring the complex biological mechanisms that these medications address.
Biology Over Willpower
Whitney Black, an Omaha-based dietitian living with type 1 diabetes, Hashimoto’s disease, and polyendocrine metabolic ovarian syndrome, describes her lifelong relationship with food as a constant battle. After the birth of her second child in March 2024, she encountered rapid weight gain and insulin resistance that defied her professional knowledge. Black realized that her hunger cues operated independently of her dietary efforts. She chose to begin a GLP-1 regimen after consulting with her endocrinologist. She now views the medication as a necessary tool for biological balance rather than a failure of personal discipline.
Summer Kessel, a dietitian in Tampa, echoes this sentiment. She spent years losing and regaining weight, a cycle that persisted despite her deep understanding of nutrition. Kessel identifies the primary issue as a biological drive—specifically, intense food noise—rather than a lack of nutritional education. For Kessel, the medication provided a quiet space in her mind where she could make food choices without the constant pressure of insatiable hunger. Since starting her maintenance dose, she reports that her health metrics have improved to levels she had never previously achieved.
Redefining Professional Expertise
The medical community is slowly shifting how it views obesity, moving toward a model that classifies it as a chronic disease rather than a character flaw. Yet, the public perception remains stuck in the past. Dietitians like Beasley, Black, and Kessel are using their social media platforms to bridge this gap. They share their personal experiences to demystify the medication and provide accurate guidance to those who feel isolated in their health struggles. They emphasize that professional training does not protect an individual from biological conditions that impact body composition.
These providers report that their transparency has built stronger trust with their own clients. Patients often feel relieved to work with a practitioner who understands the reality of living with constant hunger or metabolic resistance. By removing the shroud of secrecy around these medications, they hope to encourage a more honest conversation about evidence-based care. The path forward involves focusing on overall metabolic health, improved sleep, and reduced inflammation. These outcomes represent the success of the treatment, far outweighing the singular metric of weight loss. As the scientific consensus grows, these dietitians remain committed to helping their patients live the longest, healthiest lives possible.